Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Kylin Therapeutics to Expand Cancer Research Efforts for Its Next-Generation RNAi Platform

Abstract:
Kylin Therapeutics, Inc., a developer of next-generation RNAi therapeutics, announced the expansion of its research and development efforts. The project will advance promising new RNAi cancer therapies. This expanded effort will be conducted at Purdue University's Bindley Bioscience Center, and will focus on further validating targeted, systemically delivered cancer therapies utilizing Kylin's proprietary pRNAi platform. "Our in vivo efforts have shown pRNAi to be a very potent and versatile RNA inducing platform," said Eric Davis, the president and CEO of Kylin. "This expanded effort will enable us to test the flexibility of the pRNAi platform against various cancer targets."

Kylin Therapeutics to Expand Cancer Research Efforts for Its Next-Generation RNAi Platform

WEST LAFAYETTE, IN | Posted on October 22nd, 2008

####

About Kylin Therapeutics, Inc.
Kylin Therapeutics, Inc. is a biotechnology company focused on the development of a novel platform technology called pRNA. pRNA is a discrete, RNA-based nanoparticle system. Kylin has re-engineered pRNA to induce RNA interference (RNAi). The resulting therapeutic platform is called pRNAi. This platform represents the next generation of RNAi-inducing therapeutics with superior pharmacokinetics and potency over siRNA.

For more information, please click here

Contacts:
Kylin Therapeutics, Inc.
Eric Davis, President and CEO
(765) 412-6661

Copyright © GlobeNewswire, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Host-guest nanowires for efficient water splitting and solar energy storage February 7th, 2016

UTHealth research looks at nanotechnology to help prevent preterm birth February 7th, 2016

Graphene is strong, but is it tough? Berkeley Lab scientists find that polycrystalline graphene is not very resistant to fracture February 7th, 2016

Lithium battery catalyst found to harm key soil microorganism February 7th, 2016

Nanomedicine

UTHealth research looks at nanotechnology to help prevent preterm birth February 7th, 2016

Scientists take key step toward custom-made nanoscale chemical factories: Berkeley Lab researchers part of team that creates new function in tiny protein shell structures February 6th, 2016

Study reveals how herpes virus tricks the immune system February 5th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Announcements

Host-guest nanowires for efficient water splitting and solar energy storage February 7th, 2016

UTHealth research looks at nanotechnology to help prevent preterm birth February 7th, 2016

Graphene is strong, but is it tough? Berkeley Lab scientists find that polycrystalline graphene is not very resistant to fracture February 7th, 2016

Lithium battery catalyst found to harm key soil microorganism February 7th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic